Baroda BNP Paribas Mutual FundOther Scheme - Index Funds2 years
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 62% of rolling 1-year windows.
Prefer peers if · Prefer Edelweiss CRISIL IBX AAA Financial Services Bond - Jan 2028 Index Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
2.0 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.58% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.8%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 18.3% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 19%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
16 Dec 2024 – 9 Jun 2025
Trough 28 Feb 2025 · recovered in 101 days
-18.8%
7 Jan 2026 – 7 May 2026
Trough 30 Mar 2026 · recovered in 38 days
-14.0%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-12.7%
6 Nov 2024 – 4 Dec 2024
Trough 13 Nov 2024 · recovered in 21 days
-6.0%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
12
Vs category
47
Consistency
62
Risk-adjusted
11
Drawdown
53
Mean
37
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 151 holdings · top 10 are 18.3%.
Others CBLO
Unspecified
3.1%
Multi Commodity Exchange Of India Ltd
Financial
2.0%
The Federal Bank Ltd
Financial
1.9%
Laurus Labs Ltd
Healthcare
1.9%
One 97 Communications Ltd
Industrials
1.7%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
28 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Sept 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Edelweiss Mutual Fund
Kotak Mahindra Mutual Fund
Nippon India Mutual Fund
ICICI Prudential Mutual Fund
Caveat: Deeper drawdown
Aditya Birla Sun Life Mutual Fund
Baroda BNP Paribas Mutual FundOther Scheme - Index Funds2 years
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 62% of rolling 1-year windows.
Prefer peers if · Prefer Edelweiss CRISIL IBX AAA Financial Services Bond - Jan 2028 Index Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
2.0 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.58% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.8%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 18.3% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 19%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
29 Oct 2026 · -4.4% over 1Y
10.2168
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
29 Oct 2026
-9.9%
16 Dec 2024 – 9 Jun 2025
Trough 28 Feb 2025 · recovered in 101 days
-18.8%
7 Jan 2026 – 7 May 2026
Trough 30 Mar 2026 · recovered in 38 days
-14.0%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-12.7%
6 Nov 2024 – 4 Dec 2024
Trough 13 Nov 2024 · recovered in 21 days
-6.0%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
12
Vs category
47
Consistency
62
Risk-adjusted
11
Drawdown
53
Mean
37
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
30 Sept 2026 · 151 holdings · top 10 are 18.3%.
Others CBLO
Unspecified
3.1%
Multi Commodity Exchange Of India Ltd
Financial
2.0%
The Federal Bank Ltd
Financial
1.9%
Laurus Labs Ltd
Healthcare
1.9%
One 97 Communications Ltd
Industrials
1.7%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
29 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
28 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
27 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
26 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
21 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Sept 2026